These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33408075)

  • 21. Psoriasis and concomitant fibrosing disorders: lichen sclerosus, morphea, and systemic sclerosis.
    Walls AC; Qureshi AA
    J Am Acad Dermatol; 2012 Nov; 67(5):1079-83. PubMed ID: 23062897
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of liver function tests in scleroderma patients.
    Salem GI; Abdulrahman AA
    Rheumatol Int; 2012 Aug; 32(8):2371-5. PubMed ID: 21644046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Juvenile Scleroderma-What has Changed in the Meantime?
    Adrovic A; Sahin S; Barut K; Kasapcopur O
    Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of systemic sclerosis and related diseases.
    Mayes MD
    Curr Opin Rheumatol; 1997 Nov; 9(6):557-61. PubMed ID: 9375285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late-onset systemic sclerosis--a systematic survey of the EULAR scleroderma trials and research group database.
    Hügle T; Schuetz P; Daikeler T; Tyndall A; Matucci-Cerinic M; Walker UA; van Laar JM;
    Rheumatology (Oxford); 2011 Jan; 50(1):161-5. PubMed ID: 20884657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive treatment for systemic sclerosis-Therapeutic challenges during the COVID-19 pandemic.
    Blicharz L; Czuwara J; Samochocki Z; Goldust M; Olszewska M; Rudnicka L
    Dermatol Ther; 2020 Jul; 33(4):e13619. PubMed ID: 32428315
    [No Abstract]   [Full Text] [Related]  

  • 27. [Scleroderma in children: a retrospective study of 70 cases].
    Bodemer C; Belon M; Hamel-Teillac D; Amoric JC; Fraitag S; Prieur AM; De Prost Y
    Ann Dermatol Venereol; 1999 Oct; 126(10):691-4. PubMed ID: 10604006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexistence of systemic and localized scleroderma: a systematic literature review and observational cohort study.
    Vanhaecke A; De Schepper S; Paolino S; Heeman L; Callens H; Gutermuth J; Nguyen S; Cutolo M; Smith V
    Rheumatology (Oxford); 2020 Oct; 59(10):2725-2733. PubMed ID: 32653905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Last word with ... SUE FARRINGTON.
    Farrington S
    Community Pract; 2016 Jun; 89(6):48. PubMed ID: 27443032
    [No Abstract]   [Full Text] [Related]  

  • 30. Pediatric scleroderma.
    Emery H
    Semin Cutan Med Surg; 1998 Mar; 17(1):41-7. PubMed ID: 9512106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between occupational risk factors and severity markers of systemic sclerosis.
    Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
    J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group.
    Muntyanu A; Ouchene L; Zhou S; Hudson M; Rezaeian M; LaChance A; Litvinov IV; Baron M; Netchiporouk E;
    J Am Acad Dermatol; 2022 Nov; 87(5):1095-1097. PubMed ID: 35031410
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
    Nevskaya T; Baron M; Pope JE;
    Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry.
    Muntyanu A; Milan R; Rahme E; Baron M; Netchiporouk E;
    J Am Acad Dermatol; 2024 Mar; 90(3):605-607. PubMed ID: 37182702
    [No Abstract]   [Full Text] [Related]  

  • 35. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study.
    al-Sabbagh MR; Steen VD; Zee BC; Nalesnik M; Trostle DC; Bedetti CD; Medsger TA
    J Rheumatol; 1989 Aug; 16(8):1038-42. PubMed ID: 2585400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of eosinophilia in progressive systemic sclerosis and localized scleroderma.
    Giordano M; Ara M; Valentini G; Chianese U; Bencivenga T
    Arch Dermatol Res; 1981; 271(4):411-7. PubMed ID: 7332350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.
    Thombs BD; Kwakkenbos L; Henry RS; Carrier ME; Patten S; Harb S; Bourgeault A; Tao L; Bartlett SJ; Mouthon L; Varga J; Benedetti A; ;
    J Psychosom Res; 2020 Dec; 139():110262. PubMed ID: 33070043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of scleroderma at the Alfred Hospital, Melbourne.
    Barnett AJ
    Intern Med J; 2006 Aug; 36(8):513-8. PubMed ID: 16866656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification.
    Kaushik A; Mahajan R; De D; Handa S
    Clin Exp Dermatol; 2020 Aug; 45(6):673-678. PubMed ID: 32472964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.